Skip to Content

Inspire Medical Systems Inc INSP

Morningstar Rating
$148.51 −10.28 (6.47%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INSP is trading at a 259% premium.
Price
$159.42
Fair Value
$128.50
Uncertainty
Very High
1-Star Price
$623.35
5-Star Price
$985.46
Economic Moat
Jbf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INSP is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$158.79
Day Range
$148.17158.29
52-Week Range
$123.27330.00
Bid/Ask
$149.00 / $153.17
Market Cap
$4.41 Bil
Volume/Avg
699,669 / 585,217

Key Statistics

Price/Earnings (Normalized)
78.13
Price/Sales
6.61
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
1,011

Comparables

Valuation

Metric
INSP
TCMD
SWAV
Price/Earnings (Normalized)
78.1323.5886.15
Price/Book Value
7.481.5816.70
Price/Sales
6.611.1016.29
Price/Cash Flow
57.9015.3852.56
Price/Earnings
INSP
TCMD
SWAV

Financial Strength

Metric
INSP
TCMD
SWAV
Quick Ratio
7.123.4912.49
Current Ratio
7.934.2613.81
Interest Coverage
19.59
Quick Ratio
INSP
TCMD
SWAV

Profitability

Metric
INSP
TCMD
SWAV
Return on Assets (Normalized)
8.74%11.37%18.92%
Return on Equity (Normalized)
10.19%17.93%36.87%
Return on Invested Capital (Normalized)
6.72%13.30%20.45%
Return on Assets
INSP
TCMD
SWAV
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesMbwdstdmDgxchnr$179.0 Bil
SYK
Stryker CorpWggplyqyfYrhs$129.3 Bil
BSX
Boston Scientific CorpXyrlzzmnfLbzsqg$111.0 Bil
MDT
Medtronic PLCKjlhljkkrYldxj$107.7 Bil
EW
Edwards Lifesciences CorpKppytymmqGxtwpsg$52.9 Bil
DXCM
DexCom IncYkzbxhmxkYxzx$45.6 Bil
PHG
Koninklijke Philips NV ADRBffmpkbkQkfkqr$25.3 Bil
ZBH
Zimmer Biomet Holdings IncPnzvxpwgwvNmf$23.3 Bil
STE
Steris PLCGsngfpxpdFknktdz$22.6 Bil
ALGN
Align Technology IncQnvnbdnpdTnjyzz$19.2 Bil

Sponsor Center